Literature DB >> 3772658

Growth hormone secretion in patients with constitutional delay of growth and pubertal development.

R Lanes, L Bohorquez, V Leal, G Hernández, M Borges, E Hurtado, G Moncada.   

Abstract

Growth hormone levels were measured every 30 minutes during sleep over 9 hours in 20 prepubertal patients with constitutional delay of growth and puberty (CGD) and in 10 age-matched controls, all of whom had had normal GH responses to an orally administered dose of clonidine. We found no significant difference in the mean 9-hour overnight GH concentration between groups (4.5 +/- 1.8 ng/ml (mean +/- SD) in the CGD group, 4.4 +/- 2.8 ng/ml in the control group). Total GH output (258 +/- 99 U vs 222 +/- 135 U), total number of nocturnal GH pulses (3.6 +/- 0.8 vs 3.3 +/- 1.3), mean peak GH response during nocturnal sampling (13 +/- 1.2 ng/ml vs 13.2 +/- 1.3 ng/ml), and basal somatomedin C concentrations were not different in the children with growth delay and controls. We conclude that prepubertal patients with constitutional delay of growth and puberty secrete GH normally and do not seem to have any abnormality in GH regulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772658     DOI: 10.1016/s0022-3476(86)80693-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Final height and predicted height in boys with untreated constitutional growth delay.

Authors:  M Sperlich; O Butenandt; H P Schwarz
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

2.  Effect of two consecutive administrations of GHRH in children with constitutional growth delay.

Authors:  A Sartorio; A Spada; A Conti; F Morabito; G Faglia
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

Review 3.  Provocative growth hormone testing in children: how did we get here and where do we go now?

Authors:  Camilia Kamoun; Colin Patrick Hawkes; Adda Grimberg
Journal:  J Pediatr Endocrinol Metab       Date:  2021-04-12       Impact factor: 1.520

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.